Vinge Logotype
Svenska English 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge has advised Sdiptech AB (publ) in connection with its listing on Nasdaq Stockholm
Mandate

Vinge has advised Sdiptech AB (publ) in connection with its listing on Nasdaq Stockholm

June 11, 2021 Capital Markets and Public M&A Corporate Tax M&A

Vinge has advised Sdiptech AB (publ) in connection with its list change from Nasdaq First North Premier Growth Market to Nasdaq Stockholm’s main market. The prospectus was published on 8 June 2021 and the trading on Nasdaq Stockholm commenced on 11 June 2021.

Sdiptech is a technology group that acquires and develops market-leading niche operations that contribute to creating more sustainable, efficient and safe societies. Sdiptech has approximately SEK 2,000 million in sales and is based in Stockholm.

Vinge’s team has primarily consisted of Dain Hård Nevonen, William Kåge, Anders Sundin Lundberg and Benjamin Vafaeian (Capital Markets and Public M&A), Jesper Lindvall and Eléonore Friberg (M&A) and Victor Ericsson and Emelie Svanberg (Corporate Tax).

Related

Vinge advises ABGSC in connection with EQL Pharma’s inaugural bond issuance

 Vinge has advised ABG Sundal Collier in connection with EQL Pharma AB (publ)’s ( “EQL”) inaugural issuance of SEK 350,000,000 senior secured bonds within a framework of up to SEK 700,000.
January 24, 2025

Vinge advises the majority shareholders Altor, Telia Company, Time For Growth and Zenith VC in the divestment of shares in Marshall Group

 Vinge advises the majority shareholders Altor, Telia Company, Time For Growth and Zenith VC in connection with the divestment of shares in Marshall Group AB (publ) (”Marshall Group”) to HongShan Group, formerly known as Sequoia China. The Marshall Family will continue as owner in the Marshall Group.
January 24, 2025

Vinge represents Sedana Medical AB in the acquisition of Innovatif Cekal

 Vinge has represented Sedana Medical AB (publ) in connection with the acquisition of Innovatif Cekal. Innovatif Cekal, based in Klang near Kuala Lumpur, Malaysia, is a manufacturer of medical devices. This acquisition enhances Sedana Medical's control over its supply chain and improves profitability through reduced cost of goods.
January 22, 2025